NCT06032234

Brief Summary

The primary objective of this study is to assess the construct validity and criterion validity for associations of the VEGANScreener with nutrient intakes from reference methods and associations with biomarkers of dietary intake. The investigators hypothesize that the screener is a valid tool to assess diet quality in the vegan population. The study will assess construct validity by testing whether the measure relates as it should to other measures (e.g., age, gender, education, SES differences). The investigators will assess concurrent and predictive validity (types of criterion validity) by evaluating associations and agreement between 'gold standards', such as diet records, biomarkers, and multi-metabolite signatures of intake. The investigators will examine associations of vegan diet quality with biomarkers of nutritional status, biomarkers of disease, and anthropometric measures and hypothesize that a higher diet quality in vegans is associated with a more favourable profile among vegans, for example, a lower blood pressure. This study is part of the European VEGANScreener Consortium.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
89

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Sep 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 25, 2023

Completed
17 days until next milestone

First Posted

Study publicly available on registry

September 11, 2023

Completed
1 day until next milestone

Study Start

First participant enrolled

September 12, 2023

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2024

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2024

Completed
Last Updated

December 3, 2024

Status Verified

October 1, 2024

Enrollment Period

7 months

First QC Date

August 25, 2023

Last Update Submit

November 27, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Validity of the vegan screener

    The validity will be assessed by calculating associations between the screener and reference method.

    Baseline

Secondary Outcomes (38)

  • Dietary intake

    Baseline

  • Food habits

    Baseline

  • Vitamin D status

    Baseline

  • Homocysteine status

    Baseline

  • holo-transcobalamin

    Baseline

  • +33 more secondary outcomes

Other Outcomes (3)

  • International Physical Activity Questionnaire iPAQ

    Baseline

  • Blood pressure

    Baseline

  • Heart rate

    Baseline

Study Arms (2)

Omnivorous

Participants following an omniviours diet

Other: This is an observational study

Vegan

Participants following a vegan diet

Other: This is an observational study

Interventions

This is an observational study

OmnivorousVegan

Eligibility Criteria

Age18 Years - 65 Years
Sexall(Gender-based eligibility)
Gender Eligibility DetailsAn equal number of male and female participants will be included. Inclusion is based on self-representation of gender identity.
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Healthy participants following a vegan or omnivours diet (ratio 1:1).

You may qualify if:

  • Self-reported vegans (≥2 years on a vegan diet; vegan diet defined as not consuming any dietary animal products more often than once/month, honey excluded)
  • Self-reported omnivores. Consuming on average daily (at least 5 times/week) meat/meat products.
  • Age 18 to 65 years (1:1 ratio 18-35,99 and 36-65)
  • Males and females (1:1 ratio)

You may not qualify if:

  • Self-identified pescatarians (excluding all meat, except for fish/seafood) and reductarians/flexitarians (intentionally reducing intake of animal-based products)
  • History of a disease known to affect intermediary metabolism (e.g., any diabetes on treatment, i.e. medication or lifestyle recommendations, thyreopathies, cancer etc.)
  • BMI\>30 kg/m2
  • History of disease of intestinal integrity (i.e., inflammatory bowel disease, chronic pancreatitis, other malabsorption, etc.).
  • Pregnant or breastfeeding females.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

ETH Zurich

Zurich, Canton of Zurich, 8092, Switzerland

Location

Biospecimen

Retention: SAMPLES WITH DNA

Blood, urine and saliva samples will be collected

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Principle Investigator

Study Record Dates

First Submitted

August 25, 2023

First Posted

September 11, 2023

Study Start

September 12, 2023

Primary Completion

March 30, 2024

Study Completion

July 31, 2024

Last Updated

December 3, 2024

Record last verified: 2024-10

Locations